FDA product code PQT: Alpha-L-Iduronidase (Idua) Newborn Screening Test System
PQT is the FDA product code for alpha-l-iduronidase (idua) newborn screening test system. It is a Class II device, regulated under 21 CFR 862.1488 and reviewed by the Clinical Chemistry panel. Devices under PQT reach the market by 510(k); FDA lists no cleared 510(k)s for it.
Definition
Intended for quantitative measurement of the activity of alpha-L-iduronidase (IDUA) from newborn dried blood spot specimens.
Classification
| Field | Value |
|---|---|
| Device name | Alpha-L-Iduronidase (Idua) Newborn Screening Test System |
| Device class | Class II |
| Regulation | 21 CFR 862.1488 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
Recalls for PQT devices
openFDA lists no recalls for product code PQT.
Frequently asked questions
What is FDA product code PQT?
PQT is the FDA product code for alpha-l-iduronidase (idua) newborn screening test system. It is a Class II device, regulated under 21 CFR 862.1488 and reviewed by the Clinical Chemistry panel.
What device class is PQT?
Class II, regulation 21 CFR 862.1488. Typical premarket route: 510(k).
Next steps
- Run an FDA pathway report with predicate devices for product code PQT
- Run a recall and safety report across every PQT manufacturer
- Watch product code PQT for new clearances and recalls
Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.
All Clinical Chemistry product codes · FDA product code lookup